{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["N,O-acetyltransfer", "umu test", "HK-2 cytosols", "aristolactam-DNA adducts", "sulfonation"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31374128", "DateCompleted": {"Year": "2019", "Month": "12", "Day": "09"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "08", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1002/em.22321"], "Journal": {"ISSN": "1098-2280", "JournalIssue": {"Volume": "60", "Issue": "9", "PubDate": {"Year": "2019", "Month": "Dec"}}, "Title": "Environmental and molecular mutagenesis", "ISOAbbreviation": "Environ Mol Mutagen"}, "ArticleTitle": "Bioactivation mechanisms of N-hydroxyaristolactams: Nitroreduction metabolites of aristolochic acids.", "Pagination": {"StartPage": "792", "EndPage": "806", "MedlinePgn": "792-806"}, "Abstract": {"AbstractText": ["Aristolochic acids (AAs) are human nephrotoxins and carcinogens found in concoctions of Aristolochia plants used in traditional medicinal practices worldwide. Genotoxicity of AAs is associated with the formation of active species catalyzed by metabolic enzymes, the full repertoire of which is unknown. Recently, we provided evidence that sulfonation is important for bioactivation of AAs. Here, we employ Salmonella typhimurium umu tester strains expressing human N-acetyltransferases (NATs) and sulfotransferases (SULTs), to study the role of conjugation reactions in the genotoxicities of N-hydroxyaristolactams (AL-I-NOH and AL-II-NOH), metabolites of AA-I and AA-II. Both N-hydroxyaristolactams show stronger genotoxic effects in umu strains expressing human NAT1 and NAT2, than in the parent strain. Additionally, AL-I-NOH displays increased genotoxicity in strains expressing human SULT1A1 and SULT1A2, whereas AL-II-NOH shows enhanced genotoxicity in SULT1A1/2 and SULT1A3 strains. 2,6-Dichloro-4-nitrophenol, SULTs inhibitor, reduced umuC gene expression induced by N-hydroxyaristolactams in SULT1A2 strain. N-hydroxyaristolactams are also mutagenic in parent strains, suggesting that an additional mechanism(s) may contribute to their genotoxicities. Accordingly, using putative SULT substrates and inhibitors, we found that cytosols obtained from human kidney HK-2 cells activate N-hydroxyaristolactams in aristolactam-DNA adducts with the limited involvement of SULTs. Removal of low-molecular-weight reactants in the 3.5-10 kDa range inhibits the formation of aristolactam-DNA by 500-fold, which could not be prevented by the addition of cofactors for SULTs and NATs. In conclusion, our results demonstrate that the genotoxicities of N-hydroxyaristolactams depend on the cell type and involve not only sulfonation but also N,O-acetyltransfer and an additional yet unknown mechanism(s). Environ. Mol. Mutagen. 2019. \u00a9 2019 Wiley Periodicals, Inc."], "CopyrightInformation": "\u00a9 2019 The Authors. Environmental and Molecular Mutagenesis published by Wiley Periodicals, Inc. on behalf of Environmental Mutagen Society."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Chemistry and Biochemistry, National Institute of Technology, Wakayama College, 77 Noshima, Nada, Gobo-shi, Wakayama, 644-0023, Japan."}, {"Identifier": [], "Affiliation": "Department of Material Science and Engineering, Material Science and Engineering, Wakayama National College of Technology, Gobo-shi, Wakayama, 644-0023, Japan."}], "LastName": "Okuno", "ForeName": "Yoshiharu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, 11794, USA."}], "LastName": "Bonala", "ForeName": "Radha", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, 11794, USA."}], "LastName": "Attaluri", "ForeName": "Sivaprasad", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, 11794, USA."}, {"Identifier": [], "Affiliation": "Department of Chemistry, Stony Brook University, Stony Brook, New York, 11794, USA."}], "LastName": "Johnson", "ForeName": "Francis", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, 11794, USA."}, {"Identifier": [], "Affiliation": "Department of Medicine, Stony Brook University, Stony Brook, New York, 11794, USA."}], "LastName": "Grollman", "ForeName": "Arthur P", "Initials": "AP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, 11794, USA."}], "LastName": "Sidorenko", "ForeName": "Viktoriya S", "Initials": "VS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Life and Environmental Sciences, Osaka Shin-Ai College, 6-2-28 Tsurumi, Tsurumi-ku, Osaka, 538-0053, Japan."}], "LastName": "Oda", "ForeName": "Yoshimitsu", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Environ Mol Mutagen", "NlmUniqueID": "8800109", "ISSNLinking": "0893-6692"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Aristolochic Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Carcinogens"}, {"RegistryNumber": "0", "NameOfSubstance": "DNA Adducts"}, {"RegistryNumber": "0", "NameOfSubstance": "Mutagens"}, {"RegistryNumber": "9007-49-2", "NameOfSubstance": "DNA"}, {"RegistryNumber": "EC 2.3.1.-", "NameOfSubstance": "Acetyltransferases"}, {"RegistryNumber": "EC 2.3.1.5", "NameOfSubstance": "Arylamine N-Acetyltransferase"}, {"RegistryNumber": "EC 2.8.2.-", "NameOfSubstance": "Sulfotransferases"}, {"RegistryNumber": "EC 2.8.2.1", "NameOfSubstance": "Arylsulfotransferase"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Acetyltransferases"}, {"QualifierName": ["metabolism", "toxicity"], "DescriptorName": "Aristolochic Acids"}, {"QualifierName": ["metabolism"], "DescriptorName": "Arylamine N-Acetyltransferase"}, {"QualifierName": ["metabolism"], "DescriptorName": "Arylsulfotransferase"}, {"QualifierName": ["toxicity"], "DescriptorName": "Carcinogens"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "DNA"}, {"QualifierName": ["genetics"], "DescriptorName": "DNA Adducts"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["toxicity"], "DescriptorName": "Mutagens"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Salmonella typhimurium"}, {"QualifierName": ["metabolism"], "DescriptorName": "Sulfotransferases"}], "CoiStatement": "The authors declare no conflict of interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "\nAdministration FDA.\n2001.  Aristolochic Acid: Listing of Botanical Ingredients of Concern.[Internet]. [cited 2013 Nov 2013]. Available from: http://www.fda.gov/Food/RecallsOutbreaksEmergencies/SafetyAlertsAdvisories/ucm095283.htm."}, {"Citation": "Alexandrov LB, Jones PH, Wedge DC, Sale JE, Campbell PJ, Nik\u2010Zainal S, Stratton MR. 2015. Clock\u2010like mutational processes in human somatic cells. Nat Genet 47(12):1402\u20131407.", "ArticleIdList": ["PMC4783858", "26551669"]}, {"Citation": "Arlt VM, Meinl W, Florian S, Nagy E, Barta F, Thomann M, Mrizova I, Krais AM, Liu M, Richards M, et al. 2016. Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3\u2010nitrobenzanthrone. Arch Toxicol. 91(4):1957\u20131975.", "ArticleIdList": ["PMC5364269", "27557898"]}, {"Citation": "Attaluri S, Bonala RR, Yang IY, Lukin MA, Wen Y, Grollman AP, Moriya M, Iden CR, Johnson F. 2010. DNA adducts of aristolochic acid II: Total synthesis and site\u2010specific mutagenesis studies in mammalian cells. Nucleic Acids Res 38(1):339\u2013352.", "ArticleIdList": ["PMC2800210", "19854934"]}, {"Citation": "Attaluri S, Iden CR, Bonala RR, Johnson F. 2014. Total synthesis of the aristolochic acids, their major metabolites, and related compounds. Chem Res Toxicol 27(7):1236\u20131242.", "ArticleIdList": ["PMC4216193", "24877584"]}, {"Citation": "Bamias G, Boletis J. 2008. Balkan nephropathy: Evolution of our knowledge. Am J Kidney Dis 52(3):606\u2013616.", "ArticleIdList": ["PMC7115735", "18725017"]}, {"Citation": "Bartsch H. 1981. Metabolic activation of aromatic amines and azo dyes. IARC Sci Publ 40:13\u201330.", "ArticleIdList": ["6799396"]}, {"Citation": "Boelsterli UA, Ho HK, Zhou S, Leow KY. 2006. Bioactivation and hepatotoxicity of nitroaromatic drugs. Curr Drug Metab 7(7):715\u2013727.", "ArticleIdList": ["17073576"]}, {"Citation": "Chen CH, Dickman KG, Moriya M, Zavadil J, Sidorenko VS, Edwards KL, Gnatenko DV, Wu L, Turesky RJ, Wu XR, et al. 2012. Aristolochic acid\u2010associated urothelial cancer in Taiwan. Proc Natl Acad Sci U S A 109(21):8241\u20138246.", "ArticleIdList": ["PMC3361449", "22493262"]}, {"Citation": "Chen CJ, Yang YH, Lin MH, Lee CP, Tsan YT, Lai MN, Yang HY, Ho WC, Chen PC, Health Data Analysis in Taiwan Research G . 2018. Herbal medicine containing aristolochic acid and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. Int J Cancer. 2018. 10.1002/ijc.31544.", "ArticleIdList": ["10.1002/ijc.31544", "29667191"]}, {"Citation": "Cosyns JP, Jadoul M, Squifflet JP, Wese FX, van Ypersele de Strihou C. 1999. Urothelial lesions in Chinese\u2010herb nephropathy. Am J Kidney Dis 33(6):1011\u20131017.", "ArticleIdList": ["10352187"]}, {"Citation": "Dawson WR. 1927. Birthwort: A study of the progress of medicinal botany through twenty\u2010two centuries. Pharmaceutical J Pharmacist 396\u2010397:427\u2013430."}, {"Citation": "Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL. 1994. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 24(2):172\u2013180.", "ArticleIdList": ["8048421"]}, {"Citation": "Dong H, Suzuki N, Torres MC, Bonala RR, Johnson F, Grollman AP, Shibutani S. 2006. Quantitative determination of aristolochic acid\u2010derived DNA adducts in rats using 32P\u2010postlabeling/polyacrylamide gel electrophoresis analysis. Drug Metab Dispos 34(7):1122\u20131127.", "ArticleIdList": ["16611860"]}, {"Citation": "Fernando RC, Schmeiser HH, Scherf HR, Wiessler M. 1993. Formation and persistence of specific purine DNA adducts by 32P\u2010postlabelling in target and non\u2010target organs of rats treated with aristolochic acid I. IARC Sci Publ 124:167\u2013171.", "ArticleIdList": ["8225480"]}, {"Citation": "Gillerot G, Jadoul M, Arlt VM, van Ypersele De Strihou C, Schmeiser HH, But PP, Bieler CA, Cosyns JP. 2001. Aristolochic acid nephropathy in a Chinese patient: Time to abandon the term \"Chinese herbs nephropathy\"? Am J Kidney Dis 38(5):E26.", "ArticleIdList": ["11684578"]}, {"Citation": "Glatt H. 2000. Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact 129(1\u20132):141\u2013170.", "ArticleIdList": ["11154739"]}, {"Citation": "Gold LS, Slone TH. 2003. Aristolochic acid, an herbal carcinogen, sold on the web after FDA alert. N Engl J Med 349(16):1576\u20131577.", "ArticleIdList": ["14561805"]}, {"Citation": "Grollman AP. 2013. Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease. Environ Mol Mutagen 54(1):1\u20137.", "ArticleIdList": ["23238808"]}, {"Citation": "Grollman AP, Marcus DM. 2016. Global hazards of herbal remedies: Lessons from Aristolochia: The lesson from the health hazards of Aristolochia should lead to more research into the safety and efficacy of medicinal plants. EMBO Rep 17(5):619\u2013625.", "ArticleIdList": ["PMC5341512", "27113747"]}, {"Citation": "Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, Moll U, Suzuki N, Fernandes A, Rosenquist T, Medverec Z, et al. 2007. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci U S A 104(29):12129\u201312134.", "ArticleIdList": ["PMC1913550", "17620607"]}, {"Citation": "Hashimoto K, Zaitseva IN, Bonala R, Attaluri S, Ozga K, Iden CR, Johnson F, Moriya M, Grollman AP, Sidorenko VS. 2016. Sulfotransferase\u20101A1\u2010dependent bioactivation of aristolochic acid I and N\u2010hydroxyaristolactam I in human cells. Carcinogenesis 37(7):647\u2013655.", "ArticleIdList": ["PMC4936383", "27207664"]}, {"Citation": "Hein DW, Doll MA, Rustan TD, Gray K, Feng Y, Ferguson RJ, Grant DM. 1993. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis 14(8):1633\u20131638.", "ArticleIdList": ["8353847"]}, {"Citation": "Hoang ML, Chen CH, Sidorenko VS, He J, Dickman KG, Yun BH, Moriya M, Niknafs N, Douville C, Karchin R, et al. 2013. Mutational signature of aristolochic acid exposure as revealed by whole\u2010exome sequencing. Sci Transl Med 5(197):197ra102.", "ArticleIdList": ["PMC3973132", "23926200"]}, {"Citation": "Hoang ML, Chen CH, Chen PC, Roberts NJ, Dickman KG, Yun BH, Turesky RJ, Pu YS, Vogelstein B, Papadopoulos N, et al. 2016. Aristolochic acid in the etiology of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 25(12):1600\u20131608.", "ArticleIdList": ["PMC5533284", "27555084"]}, {"Citation": "Hollstein M, Moriya M, Grollman AP, Olivier M. 2013. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid. Mutat Res 753(1):41\u201349.", "ArticleIdList": ["PMC3689860", "23422071"]}, {"Citation": "Hsieh SC, Lin IH, Tseng WL, Lee CH, Wang JD. 2008. Prescription profile of potentially aristolochic acid containing Chinese herbal products: An analysis of National Health Insurance data in Taiwan between 1997 and 2003. Chin Med 3:13.", "ArticleIdList": ["PMC2584031", "18945373"]}, {"Citation": "Hu SL, Zhang HQ, Chan K, Mei QX. 2004. Studies on the toxicity of Aristolochia manshuriensis (Guanmuton). Toxicology 198(1\u20133):195\u2013201.", "ArticleIdList": ["15138042"]}, {"Citation": "Jelakovic B, Castells X, Tomic K, Ardin M, Karanovic S, Zavadil J. 2015. Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid. Int J Cancer 136(12):2967\u20132972.", "ArticleIdList": ["PMC4720973", "25403517"]}, {"Citation": "Kumar V, Poonam PAK, Parmar VS. 2003. Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activities. Nat Prod Rep 20(6):565\u2013583.", "ArticleIdList": ["14700200"]}, {"Citation": "Maggini V, Menniti\u2010Ippolito F, Firenzuoli F. 2018. Aristolochia, a nephrotoxic herb, still surfs on the web, 15\u2009years later. Intern Emerg Med. 13:811\u2013813.", "ArticleIdList": ["29498013"]}, {"Citation": "Meinl W, Pabel U, Osterloh\u2010Quiroz M, Hengstler JG, Glatt H. 2006. Human sulphotransferases are involved in the activation of aristolochic acids and are expressed in renal target tissue. Int J Cancer 118(5):1090\u20131097.", "ArticleIdList": ["16161050"]}, {"Citation": "Mengs U. 1988. Tumour induction in mice following exposure to aristolochic acid. Arch Toxicol 61(6):504\u2013505.", "ArticleIdList": ["3190449"]}, {"Citation": "Mengs U, Lang W, Poch JA. 1982. The carcinogenic action of Aristolochic acid in rats. Arch Toxicol 51(2):107\u2013119."}, {"Citation": "Michl J, Ingrouille MJ, Simmonds MS, Heinrich M. 2014. Naturally occurring aristolochic acid analogues and their toxicities. Nat Prod Rep 31(5):676\u2013693.", "ArticleIdList": ["24691743"]}, {"Citation": "Ng AWT, Poon SL, Huang MN, Lim JQ, Boot A, Yu W, Suzuki Y, Thangaraju S, Ng CCY, Tan P, et al. 2017. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Sci Transl Med 9(412):eaan6446.", "ArticleIdList": ["29046434"]}, {"Citation": "Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, et al. 2000. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342(23):1686\u20131692.", "ArticleIdList": ["10841870"]}, {"Citation": "Oda Y, Nakamura S, Oki I, Kato T, Shinagawa H. 1985. Evaluation of the new system (umu\u2010test) for the detection of environmental mutagens and carcinogens. Mutat Res 147(5):219\u2013229.", "ArticleIdList": ["3900709"]}, {"Citation": "Oda Y, Yamazaki H, Watanabe M, Nohmi T, Shimada T. 1993. Highly sensitive umu test system for the detection of mutagenic nitroarenes in salmonella typhimurium NM3009 having high O\u2010acetyltransferase and nitroreductase activities. Environ Mol Mutagen 21(4):357\u2013364.", "ArticleIdList": ["8491215"]}, {"Citation": "Oda Y, Yamazaki H, Watanabe M, Nohmi T, Shimada T. 1995. Development of high sensitive umu test system: Rapid detection of genotoxicity of promutagenic aromatic amines by salmonella typhimurium strain NM2009 possessing high O\u2010acetyltransferase activity. Mutat Res 334(2):145\u2013156.", "ArticleIdList": ["7885366"]}, {"Citation": "Oda Y, Yamazaki H, Shimada T. 1999. Role of human N\u2010acetyltransferases, NAT1 or NAT2, in genotoxicity of nitroarenes and aromatic amines in salmonella typhimurium NM6001 and NM6002. Carcinogenesis 20(6):1079\u20131083.", "ArticleIdList": ["10357791"]}, {"Citation": "Oda Y, Zhang Y, Buchinger S, Reifferscheid G, Yang M. 2012. Roles of human sulfotransferases in genotoxicity of carcinogens using genetically engineered umu test strains. Environ Mol Mutagen 53(2):152\u2013164.", "ArticleIdList": ["22072630"]}, {"Citation": "Petljak M, Alexandrov LB. 2016. Understanding mutagenesis through delineation of mutational signatures in human cancer. Carcinogenesis 37(6):531\u2013540.", "ArticleIdList": ["27207657"]}, {"Citation": "Pfau W, Pool\u2010Zobel BL, von der Lieth CW, Wiessler M. 1990a. The structural basis for the mutagenicity of aristolochic acid. Cancer Lett 55(1):7\u201311.", "ArticleIdList": ["2245413"]}, {"Citation": "Pfau W, Schmeiser HH, Wiessler M. 1990b. 32P\u2010postlabelling analysis of the DNA adducts formed by aristolochic acid I and II. Carcinogenesis 11(9):1627\u20131633.", "ArticleIdList": ["2401053"]}, {"Citation": "Pfau W, Schmeiser HH, Wiessler M. 1990c. Aristolochic acid binds covalently to the exocyclic amino group of purine nucleotides in DNA. Carcinogenesis 11(2):313\u2013319.", "ArticleIdList": ["2302759"]}, {"Citation": "Poon SL, Pang ST, McPherson JR, Yu W, Huang KK, Guan P, Weng WH, Siew EY, Liu Y, Heng HL, et al. 2013. Genome\u2010wide mutational signatures of aristolochic acid and its application as a screening tool. Sci Transl Med 5(197):197ra101.", "ArticleIdList": ["23926199"]}, {"Citation": "Poon SL, Huang MN, Choo Y, McPherson JR, Yu W, Heng HL, Gan A, Myint SS, Siew EY, Ler LD, et al. 2015. Mutation signatures implicate aristolochic acid in bladder cancer development. Genome Med 7(1):38.", "ArticleIdList": ["PMC4443665", "26015808"]}, {"Citation": "Priestap HA, de los Santos C, Quirke JM. 2010. Identification of a reduction product of aristolochic acid: Implications for the metabolic activation of carcinogenic aristolochic acid. J Nat Prod 73(12):1979\u20131986.", "ArticleIdList": ["PMC3040066", "21141875"]}, {"Citation": "Priestap HA, Barbieri MA, Johnson F. 2012. Aristoxazole analogues. Conversion of 8\u2010nitro\u20101\u2010naphthoic acid to 2\u2010methylnaphtho[1,2\u2010d]oxazole\u20109\u2010carboxylic acid: Comments on the chemical mechanism of formation of DNA adducts by the aristolochic acids. J Nat Prod 75(7):1414\u20131418.", "ArticleIdList": ["22746540"]}, {"Citation": "Purohit V, Basu AK. 2000. Mutagenicity of nitroaromatic compounds. Chem Res Toxicol 13(8):673\u2013692.", "ArticleIdList": ["10956054"]}, {"Citation": "Reddy MV, Randerath K. 1986. Nuclease P1\u2010mediated enhancement of sensitivity of 32P\u2010postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7(9):1543\u20131551.", "ArticleIdList": ["3017601"]}, {"Citation": "National Toxicology Program . 2011. NTP 12th report on carcinogens. Rep Carcinog 12:45\u201349.", "ArticleIdList": ["21822324"]}, {"Citation": "Romanov V, Whyard TC, Waltzer WC, Grollman AP, Rosenquist T. 2015. Aristolochic acid\u2010induced apoptosis and G2 cell cycle arrest depends on ROS generation and MAP kinases activation. Arch Toxicol 89(1):47\u201356.", "ArticleIdList": ["24792323"]}, {"Citation": "Rosenquist TA, Grollman AP. 2016. Mutational signature of aristolochic acid: Clue to the recognition of a global disease. DNA Repair (Amst) 44:205\u2013211.", "ArticleIdList": ["27237586"]}, {"Citation": "Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok\u2010Storb B. 1994. HK\u20102: An immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45(1):48\u201357.", "ArticleIdList": ["8127021"]}, {"Citation": "Sato N, Takahashi D, Chen SM, Tsuchiya R, Mukoyama T, Yamagata S, Ogawa M, Yoshida M, Kondo S, Satoh N, et al. 2004. Acute nephrotoxicity of aristolochic acids in mice. J Pharm Pharmacol 56(2):221\u2013229.", "ArticleIdList": ["15005881"]}, {"Citation": "Scelo G, Riazalhosseini Y, Greger L, Letourneau L, Gonzalez\u2010Porta M, Wozniak MB, Bourgey M, Harnden P, Egevad L, Jackson SM, et al. 2014. Variation in genomic landscape of clear cell renal cell carcinoma across Europe. Nat Commun 5:5135.", "ArticleIdList": ["25351205"]}, {"Citation": "Schmeiser HH, Pool BL, Wiessler M. 1984. Mutagenicity of the two main components of commercially available carcinogenic aristolochic acid in salmonella typhimurium. Cancer Lett 23(1):97\u2013101.", "ArticleIdList": ["6378360"]}, {"Citation": "Schmeiser HH, Pool BL, Wiessler M. 1986. Identification and mutagenicity of metabolites of aristolochic acid formed by rat liver. Carcinogenesis 7(1):59\u201363.", "ArticleIdList": ["3510750"]}, {"Citation": "Schmeiser HH, Schoepe KB, Wiessler M. 1988. DNA adduct formation of aristolochic acid I and II in vitro and in vivo. Carcinogenesis 9(2):297\u2013303.", "ArticleIdList": ["3338114"]}, {"Citation": "Schmeiser HH, Janssen JW, Lyons J, Scherf HR, Pfau W, Buchmann A, Bartram CR, Wiessler M. 1990. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues. Cancer Res 50(17):5464\u20135469.", "ArticleIdList": ["2201437"]}, {"Citation": "Schmeiser HH, Scherf HR, Wiessler M. 1991. Activating mutations at codon 61 of the c\u2010ha\u2010ras gene in thin\u2010tissue sections of tumors induced by aristolochic acid in rats and mice. Cancer Lett 59(2):139\u2013143.", "ArticleIdList": ["1884371"]}, {"Citation": "Schmeiser HH, Nortier JL, Singh R, Gamboa da Costa G, Sennesael J, Cassuto\u2010Viguier E, Ambrosetti D, Rorive S, Pozdzik A, Phillips DH, et al. 2014. Exceptionally long\u2010term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy. Int J Cancer 135(2):502\u2013507.", "ArticleIdList": ["24921086"]}, {"Citation": "Seah VM, Wong KP. 1994. 2,6\u2010Dichloro\u20104\u2010nitrophenol (DCNP), an alternate\u2010substrate inhibitor of phenolsulfotransferase. Biochem Pharmacol 47(10):1743\u20131749.", "ArticleIdList": ["8204091"]}, {"Citation": "Shibutani S, Kim SY, Suzuki N. 2006. 32P\u2010postlabeling DNA damage assays: PAGE, TLC, and HPLC. Methods Mol Biol 314:307\u2013321.", "ArticleIdList": ["16673890"]}, {"Citation": "Shibutani S, Dong H, Suzuki N, Ueda S, Miller F, Grollman AP. 2007. Selective toxicity of aristolochic acids I and II. Drug Metab Dispos 35(7):1217\u20131222.", "ArticleIdList": ["17392392"]}, {"Citation": "Sidorenko VS, Yeo JE, Bonala RR, Johnson F, Scharer OD, Grollman AP. 2012. Lack of recognition by global\u2010genome nucleotide excision repair accounts for the high mutagenicity and persistence of aristolactam\u2010DNA adducts. Nucleic Acids Res 40(6):2494\u20132505.", "ArticleIdList": ["PMC3315299", "22121226"]}, {"Citation": "Sidorenko VS, Attaluri S, Zaitseva I, Iden CR, Dickman KG, Johnson F, Grollman AP. 2014. Bioactivation of the human carcinogen aristolochic acid. Carcinogenesis 35(8):1814\u20131822.", "ArticleIdList": ["PMC4123648", "24743514"]}, {"Citation": "Stiborova M, Frei E, Arlt VM, Schmeiser HH. 2009. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: Urgent questions and difficult answers. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 153(1):5\u201311.", "ArticleIdList": ["19365519"]}, {"Citation": "Stiborova M, Mares J, Frei E, Arlt VM, Martinek V, Schmeiser HH. 2011. The human carcinogen aristolochic acid i is activated to form DNA adducts by human NAD(P)H:Quinone oxidoreductase without the contribution of acetyltransferases or sulfotransferases. Environ Mol Mutagen 52(6):448\u2013459.", "ArticleIdList": ["21370283"]}, {"Citation": "Stiborova M, Martinek V, Frei E, Arlt VM, Schmeiser HH. 2013. Enzymes metabolizing aristolochic acid and their contribution to the development of aristolochic acid nephropathy and urothelial cancer. Curr Drug Metab 14(6):695\u2013705.", "ArticleIdList": ["23701164"]}, {"Citation": "Tada M, Tada M. 1975. Seryl\u2010tRNA synthetase and activation of the carcinogen 4\u2010nitroquinoline\u20101\u2010oxide. Nature 255:510\u2013512.", "ArticleIdList": ["166317"]}, {"Citation": "\nTay C.\n2019.  TGA advises \"extreme caution\" after detecting cancer\u2010causing contaminants in Chinese herbal pills. Available from: https://www.nutraingredients-asia.com/Article/2019/2001/2014/TGA-advises-extreme-caution-after-detecting-cancer-causing-contaminants-in-Chinese-herbal-pills#."}, {"Citation": "Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato M, Tsuji S, Donehower LA, Slagle BL, Nakamura H, et al. 2014. Trans\u2010ancestry mutational landscape of hepatocellular carcinoma genomes. Nat Genet 46(12):1267\u20131273.", "ArticleIdList": ["25362482"]}, {"Citation": "Turesky RJ, Yun BH, Brennan P, Mates D, Jinga V, Harnden P, Banks RE, Blanche H, Bihoreau MT, Chopard P, et al. 2016. Aristolochic acid exposure in Romania and implications for renal cell carcinoma. Br J Cancer 114(1):76\u201380.", "ArticleIdList": ["PMC4716534", "26657656"]}, {"Citation": "Vaclavik L, Krynitsky AJ, Rader JI. 2014. Quantification of aristolochic acids I and II in herbal dietary supplements by ultra\u2010high\u2010performance liquid chromatography\u2010multistage fragmentation mass spectrometry. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 31(5):784\u2013791.", "ArticleIdList": ["24512293"]}, {"Citation": "Vanherweghem LJ. 1998. Misuse of herbal remedies: The case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Complement Med 4(1):9\u201313.", "ArticleIdList": ["9553830"]}, {"Citation": "Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, Richard C, Vandervelde D, Verbeelen D, Vanhaelen\u2010Fastre R, Vanhaelen M. 1993. Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs. Lancet 341(8842):387\u2013391.", "ArticleIdList": ["8094166"]}, {"Citation": "World Health Organization . 2008. Some traditional herbal medicines, some mycotoxins, naphthalene and styrene IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: IARC Press.", "ArticleIdList": ["PMC4781602", "12687954"]}, {"Citation": "Wu TK, Wei CW, Pan YR, Cherng SH, Chang WJ, Wang HF, Yu YL. 2015. Vitamin C attenuates the toxic effect of aristolochic acid on renal tubular cells via decreasing oxidative stressmediated cell death pathways. Mol Med Rep 12(4):6086\u20136092.", "ArticleIdList": ["26239057"]}, {"Citation": "Xing G, Qi X, Chen M, Wu Y, Yao J, Gong L, Nohmi T, Luan Y, Ren J. 2012. Comparison of the mutagenicity of aristolochic acid I and aristolochic acid II in the gpt delta transgenic mouse kidney. Mutat Res 743(1\u20132):52\u201358.", "ArticleIdList": ["22245565"]}, {"Citation": "Yu FY, Wu TS, Chen TW, Liu BH. 2011. Aristolochic acid I induced oxidative DNA damage associated with glutathione depletion and ERK1/2 activation in human cells. Toxicol In Vitro 25(4):810\u2013816.", "ArticleIdList": ["21300145"]}, {"Citation": "Zou S, Li J, Zhou H, Frech C, Jiang X, Chu JS, Zhao X, Li Y, Li Q, Wang H, et al. 2014. Mutational landscape of intrahepatic cholangiocarcinoma. Nat Commun 5:5696.", "ArticleIdList": ["25526346"]}]}], "History": [{"Year": "2019", "Month": "5", "Day": "31"}, {"Year": "2019", "Month": "7", "Day": "19"}, {"Year": "2019", "Month": "7", "Day": "30"}, {"Year": "2019", "Month": "8", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "8"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31374128", "PMC6899766", "10.1002/em.22321"]}}]}